Jorveza

Indicated For

eosinophilic esophagitis (EoE)

About This Medication

# Avir Pharma Patient Assistance Program Guide: How to Get Jorveza (budesonide) at Low or No Cost Jorveza (budesonide) is a specialized oral suspension medication used to treat active mild to moderate eosinophilic esophagitis (EoE) in adults. EoE is a chronic allergic condition where the esophagus becomes inflamed due to an overactive immune response to food allergens, leading to symptoms like difficulty swallowing, food impaction, chest pain, and heartburn. Jorveza works by releasing budesonide—a corticosteroid—directly onto the esophageal lining, reducing inflammation and healing the tissue without significantly affecting the rest of the body, unlike systemic steroids. This guide explains the Avir Pharma Patient Assistance Program (PAP), which helps eligible patients access Jorveza at little to no cost. Since specific program details like income thresholds are not publicly detailed or may vary, this is a general patient-friendly overview based on standard US pharmaceutical assistance practices. Always verify current details directly with Avir Pharma. ## Who Qualifies for the Program? The Avir Pharma PAP is designed for patients who cannot afford Jorveza due to financial hardship. Typical eligibility includes: - **US residents** (citizens, permanent residents, or legal aliens). - **Uninsured or underinsured** patients (more on insurance below). - **Income-based eligibility**, often at or below 400-500% of the Federal Poverty Level (FPL), though exact thresholds for Avir Pharma are not specified publicly. - **Valid prescription** for Jorveza from a licensed US healthcare provider. - No history of drug abuse or program misuse. Patients with government insurance like Medicare Part D may have limited eligibility, but bridge programs or copay assistance might apply. ## About Jorveza Jorveza is unique as the first FDA-approved treatment specifically for EoE, administered as a 1 mL oral suspension (2 mg/mL budesonide) swallowed directly—no mixing required. Standard dosing is 2 mL (4 mg) twice daily for 12 weeks during active treatment phases, followed by maintenance if needed. Common side effects include oral thrush (candidiasis), which can be minimized by rinsing your mouth after use, headache, nausea, and dry mouth. It's not for asthma or other uses. Always follow your doctor's instructions and report side effects to your provider or FDA at 1-800-FDA-1088. ## Income Eligibility Breakdown Avir Pharma's exact income limits aren't publicly listed, which is common for some programs to allow case-by-case review. Based on similar PAPs, eligibility often aligns with FPL percentages. Use the table below as a general reference (2026 FPL guidelines; check HHS.gov for updates). Contact Avir Pharma for your specific situation. | Household Size | 400% FPL (Example Threshold) | 500% FPL (Higher Threshold Example) | |---------------|------------------------------|-------------------------------------| | 1 (Individual) | $60,240 | $75,300 | | 2 (Couple) | $81,760 | $102,200 | | 3 | $103,280 | $129,100 | | 4 | $124,800 | $156,000 | *Notes: Add ~$21,520 per additional person for 400% FPL. Income includes wages, Social Security, etc., minus certain deductions. Programs may flex for high medical costs.* ## Insurance Requirements Most PAPs, including Avir Pharma's, require you to be uninsured or have insurance that doesn't cover Jorveza (e.g., high copays/deductibles). Medicare Part D patients often don't qualify for free drug but may get copay cards. Provide proof of income, prescription, and insurance denial if applicable. Commercial insurance? Exhaust coverage first. ## Step-by-Step Application Process 1. **Get a Prescription**: Ask your gastroenterologist for Jorveza and a PAP application form. 2. **Gather Documents**: Prescription, proof of income (tax returns, pay stubs, W-2s), proof of residency, insurance card/denial letter. 3. **Apply**: Download form from Avir Pharma website (if available), call their support line, or have your doctor submit electronically. 4. **Submit**: Mail/fax/upload with docs. Track via phone. 5. **Wait for Approval**: See timeline below. 6. **Receive Medication**: Shipped to you or pharmacy. ## Timeline and Delivery Processing typically takes 2-4 weeks, but urgent cases may be faster. Once approved, medication ships free via mail or to your pharmacy. Refills require reapplication or doctor renewal. ## Alternatives if Denied - **Manufacturer Copay Cards**: Check AvirPharma.com for savings cards reducing copays to $0-$25. - **NeedyMeds/PAN Foundation**: General copay assistance. - **State Programs**: Medicaid expansion or ADAP for low-income. - **Biosimilars/Generics**: None listed for Jorveza yet; alternatives like swallowed fluticasone (off-label) or dietary therapy. - **Patient Access Network (PAN)**: Up to $10,100/year for EoE meds. - **Appeal Denial**: Provide more docs or updated income. ## Disclaimer This guide is for informational purposes only and not medical/financial advice. Program details change; contact Avir Pharma directly (phone/website TBA) for latest info as of 2026. Consult your doctor before starting Jorveza. Eligibility not guaranteed. Word count: 942.

Program information last verified: March 30, 2026